CiPA: Ongoing testing, future qualification procedures, and pending issues

Simulation of the Undiseased Human Cardiac Ventricular Action Potential: Model Formulation and Experimental Validation

Tom O’Hara, László Virág, András Varró et al. · PLoS Computational Biology · 2011 · 1.2K citations · Full text

Medicine, Cardiology, Physiology +17

Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium

Philip T. Sager, Gary A. Gintant, J. Rick Turner et al. · American Heart Journal · 2013 · 548 citations · Full text

Medicine, Cardiology, Pharmacology +15

Drug Screening Using a Library of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity

Ping Liang, Feng Lan, Andrew S. Lee et al. · Circulation · 2013 · 537 citations · Full text

Medicine, Cardiology, Pharmacology +13

Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications

Anurag Mathur, Peter Loskill, Kaifeng Shao et al. · Scientific Reports · 2015 · 516 citations · Full text

Medicine, Cardiology, Pharmacology +17

Instability and Triangulation of the Action Potential Predict Serious Proarrhythmia, but Action Potential Duration Prolongation Is Antiarrhythmic

Luc M. Hondeghem, Leif Carlsson, Göran Duker · Circulation · 2001 · 505 citations

Medicine, Cardiology, Pharmacology +16